Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)MYnd Analytics Directed Therapy in Depression
Phase 4
- Conditions
- Depression
- First Posted Date
- 2017-11-01
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Cota Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT03328052
- Locations
- 🇺🇸
Hackensack Meridian Health Network, Toms River, New Jersey, United States
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Terminated
- Conditions
- Metastatic MelanomaMetastatic Lung CancerMetastatic Colon CancerMetastatic Prostate CancerPancreatic CancerMetastatic Breast Cancer
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- Cota Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03073473
- Locations
- 🇺🇸
RCCA - Central Jersey Division, East Brunswick, New Jersey, United States
🇺🇸RCCA - Freehold Division, Freehold, New Jersey, United States
🇺🇸Hackensack Meridian Health System, Hackensack, New Jersey, United States
Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
Terminated
- Conditions
- Carcinoma, Non-small Cell Lung
- First Posted Date
- 2016-02-02
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- Cota Inc.
- Target Recruit Count
- 649
- Registration Number
- NCT02671045
- Locations
- 🇺🇸
COTA, New York, New York, United States
News
No news found